Survey of Ophthalmology
Volume 48, Issue 4 , Pages 369-388, July 2003

Ligneous conjunctivitis

  • Volker Schuster, MD

      Affiliations

    • Department of Pediatrics, Leipzig University Medical School, Leipzig, Germany
    • Corresponding Author InformationReprint address: Volker Schuster, MD, Department of Pediatrics, Leipzig University Medical School, Oststrasse 21-25, D-04317 Leipzig, Germany
  • ,
  • Stefan Seregard, MD, PhD

      Affiliations

    • Ophthalmic Pathology and Oncology Service, Saint Eriks Eye Hospital and Karolinska Institute, Stockholm, Sweden

Abstract 

Ligneous conjunctivitis (McKusick 217090) is a rare form of chronic conjunctivitis characterized by the development of firm fibrin-rich, woody-like pseudomembraneous lesions mainly on the tarsal conjunctivae. Less frequently, similar lesions may occur on other mucous membranes of the body indicating that these manifestations are part of a systemic disease. Histopathological findings from affected humans and (plasminogen-deficient) mice indicate that wound healing, mainly of injured mucosal tissue, is impaired due to markedly decreased (plasmin-mediated) extracellular fibrinolysis. Pseudomembraneous lesions of the eyes and other mucosal tissue mainly contain clotted fibrin(ogen). Actually, systemic plasminogen deficiency has been linked to ligneous conjunctivitis in humans and mice. In one case, ligneous conjunctivitis has been induced by antifibrinolytic treatment with tranexamic acid. Further rare associated disorders of ligneous conjunctivitis are congenital occlusive hydrocephalus and juvenile colloid milium. This review outlines the historical background, clinical characteristics of ligneous conjunctivitis and its associated complications, histological abnormalities of pseudomembraneous lesions, inheritance, hemostasiologic and molecular genetic findings in affected patients, current treatment approaches, and the plasminogen-deficient mouse as an animal model.

Keywords:  ligneous conjunctivitis, plasminogen-deficient mice, systemic manifestations, treatment options, type I plasminogen deficiency

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by the Deutsche Forschungsgemeinschaft (grant Schu 560/4-3). The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(03)00056-0

doi:10.1016/S0039-6257(03)00056-0

Survey of Ophthalmology
Volume 48, Issue 4 , Pages 369-388, July 2003